Your browser doesn't support javascript.
loading
Lack of association between the CARD10 rs6000782 polymorphism and type 1 autoimmune hepatitis in a Japanese population.
Migita, Kiyoshi; Jiuchi, Yuka; Furukawa, Hiroshi; Nakamura, Minoru; Komori, Atsumasa; Yasunami, Michio; Kozuru, Hideko; Abiru, Seigo; Yamasaki, Kazumi; Nagaoka, Shinya; Hashimoto, Satoru; Bekki, Shigemune; Yoshizawa, Kaname; Shimada, Masaaki; Kouno, Hiroshi; Kamitsukasa, Hiroshi; Komatsu, Tatsuji; Hijioka, Taizo; Nakamuta, Makoto; Naganuma, Atsushi; Yamashita, Haruhiro; Nishimura, Hideo; Ohta, Hajime; Nakamura, Yoko; Ario, Keisuke; Oohara, Yukio; Sugi, Kazuhiro; Tomizawa, Minoru; Sato, Takeaki; Takahashi, Hironao; Muro, Toyokichi; Makita, Fujio; Mita, Eiji; Sakai, Hironori; Yatsuhashi, Hiroshi.
Affiliation
  • Migita K; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. migita@nagasaki-mc.com.
  • Jiuchi Y; Clinical Research Center, NHO Nagasaki Medical Center, Kubara 2-1001-1, Omura, 856-8652, Japan. migita@nagasaki-mc.com.
  • Furukawa H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. jiuchi@nagasaki-mc.com.
  • Nakamura M; Department of Rheumatology, NHO Sagamihara Hospital, Minamikusakuradai 18-1, Sagamihara, Kanagawa, 252-0392, Japan. furukawa-tky@umin.org.
  • Komori A; Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-12-4, Ngasaki, Nagasaki, 852-8523, Japan. nakamuram@nagasaki-mc.com.
  • Yasunami M; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. komori@nagasaki-mc.com.
  • Kozuru H; Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Sakamoto 1-12-4, Ngasaki, Nagasaki, 852-8523, Japan. yasunami@nagasaki-u.ac.jp.
  • Abiru S; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. hkozuru@nagasaki-mc.com.
  • Yamasaki K; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. s.abiru@nagasaki-mc.com.
  • Nagaoka S; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. k.yamasaki@nagasaki-mc.com.
  • Hashimoto S; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. sinagaoka@nagasaki-mc.com.
  • Bekki S; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. shashimoto@nagasaki-mc.com.
  • Yoshizawa K; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. bekki@nagasaki-mc.com.
  • Shimada M; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. k.yoshizawa@nagano-hosp.go.jp.
  • Kouno H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. shimada@nnh.hosp.go.jp.
  • Kamitsukasa H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. hkouno@kure-nh.go.jp.
  • Komatsu T; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. kamihiro-in@tokyo-hosp.jp.
  • Hijioka T; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. tkoma@hosp.go.jp.
  • Nakamuta M; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. hijioka@ommc-hp.jp.
  • Naganuma A; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. nakamuta@kyumed.jp.
  • Yamashita H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. numackey@pa2.so-net.ne.jp.
  • Nishimura H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. haruymst@okayama3.hosp.go.jp.
  • Ohta H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. nishim-1@hosp.go.jp.
  • Nakamura Y; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. h-ohta@kinbyou.hosp.go.jp.
  • Ario K; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. nakamury-1@hosp.go.jp.
  • Oohara Y; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. ariok@uresino.go.jp.
  • Sugi K; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. ooharay@hok-mc.hosp.go.jp.
  • Tomizawa M; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. sugi@kumamed.jp.
  • Sato T; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. nihminor-cib@umin.ac.jp.
  • Takahashi H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. satot@kokura2.hosp.go.jp.
  • Muro T; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. dr.hr.tkhs.meddr@s8.dion.ne.jp.
  • Makita F; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. muro@oita2.hosp.go.jp.
  • Mita E; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. makitaf@netnngh.hosp.go.jp.
  • Sakai H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. eijim67@onh.go.jp.
  • Yatsuhashi H; NHO-AIH study group, Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki, 856-8562, Japan. hsakai@hosp.go.jp.
BMC Res Notes ; 8: 777, 2015 Dec 12.
Article in En | MEDLINE | ID: mdl-26652023
ABSTRACT

BACKGROUND:

Previous genome-wide association studies have evaluated the impact of common genetic variants and identified several non-HLA risk loci associated with autoimmune liver diseases. More recent genome-wide association studies and replication analyses reported an association between variants of the CARD10 polymorphism rs6000782 and risk of type 1 autoimmune hepatitis (AIH). In this case-control study, we genotyped 326 Japanese AIH patients and 214 control subjects.

RESULTS:

Genomic DNA from 540 individuals of Japanese origin, including 326 patients with type-1 AIH and 214 healthy controls, was analyzed for two single nucleotide polymorphisms (SNPs) in the CARD10 gene. We selected CARD10 rs6000782 SNPs and genotyped these using PCR-RFLP method and direct sequencing. The Chi square test revealed that the rs6000782 variant alle (c) was not associated with the susceptibility for AIH in a Japanese population [p = 0.376, odds ratio (OR) 1.271, 95 % confidence interval (CI) 0.747-2.161] in an allele model. Our data also showed that CARD10 rs6000782 variants were not associated with AIH or with the clinical parameters of AIH.

CONCLUSIONS:

In this study we examined an association between rs6000782 SNPs in the CARD10 gene and type-1 AIH. Results showed no significant association of rs62000782 with type-1 AIH in a Japanese population. This study demonstrated no association between CARD10 rs6000782 variants and AIH in a Japanese population.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis, Autoimmune / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / CARD Signaling Adaptor Proteins Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Res Notes Year: 2015 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis, Autoimmune / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / CARD Signaling Adaptor Proteins Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Res Notes Year: 2015 Document type: Article Affiliation country: Japan